Hi there,
This Saturday kicks off the 2026 American College of Cardiology Scientific Sessions in New Orleans.
Experts from the University of Michigan Health Frankel Cardiovascular Center will be there to present and lead discussion surrounding advances in cardiovascular medicine and care.
This includes featured clinical science on using digital health to reduce CV risk, and investigative advances on therapy for genetic heart disease:
Nicole Bhave, M.D., FACC, is the conference vice chair-elect and will be giving a press conference on late-breaking science: Discontinuation of β-blocker Therapy in Stabilized Patients After Acute Myocardial Infarction – March 30, 8:30 a.m. CT
We also have other members available for expert comment on other late-breaking clinical trials and featured clinical research (below my signature).
If you are interested in covering our abstract or getting comment from an expert, please reach out!
Thanks,
Noah Fromson (He/Him/His)
Lead Public Relations Specialist & Medical Content Producer
Frankel Cardiovascular Center, Neurosciences, Kahn Pavilion, Broadcast Clips
C: (216) 509-8604
U-M Health Frankel Cardiovascular Center Available Experts (alphabetical)
- Eric J. Brandt, M.D., M.H.S., is a cardiologist/lipidologist and an assistant professor of internal medicine-cardiology at U-M Medical School. He is the director of preventive cardiology at the U-M Health Frankel Cardiovascular Center. His research in health services research is funded by the NIH.
- Kent Brummel, M.D., is a general cardiologist, lipidologist and echocardiographer at the U-M Health Frankel Cardiovascular Center. He is also a clinical assistant professor of internal medicine-cardiology at U-M Medical School. He has a focus in the management of complex cholesterol conditions.
- Aman Chugh, M.D., is a cardiac electrophysiologist and Director of Section of Cardiac Electrophysiology at the U-M Health Frankel Cardiovascular Center. He specializes in catheter ablation of complex ablation procedures for atrial fibrillation and also left atrial appendage occlusion devices. His research interests focus on mechanisms and catheter ablation of atrial fibrillation and related arrhythmias.
- Scott Hummel, M.D., M.S., is a heart failure and transplant cardiologist and professor of internal medicine-cardiology at U-M Medical School. His research focuses on the role of diet and nutrition in heart failure; he conducted the first NIH-funded dietary intervention in heart failure with preserved ejection fraction and the first NIH-funded post-discharge nutritional support intervention in heart failure. He leads several active studies investigating “Food is Medicine” approaches to preventing and managing heart failure.
- Pamela Marcovitz, M.D., FACC, is a cardiologist at the U-M Health Frankel Cardiovascular Center cardiologist specializing in POTS and cardiovascular disease in women, and a nationally recognized advocate for women’s heart health. She is also an associate professor of internal medicine-cardiology at U-M Medical School. She has authored over 40 publications and held leadership roles with the American Heart Association and WomenHeart.
- Venkatesh L. Murthy, M.D., Ph.D. – is the Melvyn Rubenfire Professor of Preventive Cardiology at the University of Michigan and associate chief of cardiology for translational research and innovation. He is an expert in cardiometabolic disease, subclinical atherosclerosis, coronary vasomotor dysfunction, cardiovascular imaging and the application of AI and advanced quantitative methods to these arenas.
- Brett Wanamaker, M.D., FACC, is an interventional cardiologist at the U-M Health Frankel Cardiovascular Center and is an associate professor of internal medicine-cardiology at U-M Medical School. Clinically, he specializes in complex and high-risk coronary interventions. His academic interests include procedural decision-making, quality of care in percutaneous coronary revascularization and enhancing the understanding of risk/benefit in revascularization procedures.